Chapter 1. Stem Cell Therapy Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Stem Cell Therapy Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
           2.2.1    Demand Side
           2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Stem Cell Therapy Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Stem Cell Therapy Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
           4.5.1    Bargaining Power of Suppliers
           4.5.2    Bargaining Powers of Customers
           4.5.3    Threat of New Entrants
           4.5.4    Rivalry among Existing Players
           4.5.5    Threat of Substitutes 
Chapter 5. Stem Cell Therapy Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Stem Cell Therapy Market – By Therapy Type
6.1    Introduction/Key Findings   
6.2    Allogeneic Therapy 
6.3    Autologous Therapy 
6.4    Y-O-Y Growth trend Analysis By Therapy Type
6.5    Absolute $ Opportunity Analysis By Therapy Type, 2024-2030 
Chapter 7. Stem Cell Therapy Market – By Indication
7.1    Introduction/Key Findings   
7.2    Autoimmune Diseases 
7.3    Musculoskeletal Disorders 
7.4    Acute Graft Host Disease 
7.5    Trauma Injuries  
7.6    Others 
7.7    Y-O-Y Growth  trend Analysis By Indication
7.8    Absolute $ Opportunity Analysis By Indication, 2024-2030 
Chapter 8. Stem Cell Therapy Market – By Cell Type
8.1    Introduction/Key Findings   
8.2    Embryonic Stem Cells
8.3    Tissue-specific Stem Cells 
8.4    Mesenchymal Stem Cells  
8.5    Induced Pluripotent Stem Cells 
8.6    Y-O-Y Growth trend Analysis By Cell Type
8.7    Absolute $ Opportunity Analysis By Cell Type, 2024-2030
Chapter 9. Stem Cell Therapy Market – By End-User
9.1    Introduction/Key Findings   
9.2    Hospitals
9.3    Acute Care Facilities
9.4    Specialized Clinics
9.5    Y-O-Y Growth trend Analysis End-User
9.6    Absolute $ Opportunity Analysis End-User, 2024-2030
Chapter 10. Stem Cell Therapy Market , By Geography – Market Size, Forecast, Trends & Insights
10.1    North America
           10.1.1    By Country
                      10.1.1.1    U.S.A.
                      10.1.1.2    Canada
                      10.1.1.3    Mexico
           10.1.2    By Therapy Type
                      10.1.2.1    By Indication
           10.1.3    By Cell Type
           10.1.4    Countries & Segments - Market Attractiveness Analysis
10.2    Europe
           10.2.1    By Country
                      10.2.1.1    U.K
                      10.2.1.2    Germany
                      10.2.1.3    France
                      10.2.1.4    Italy
                      10.2.1.5    Spain
                      10.2.1.6    Rest of Europe
           10.2.2    By Therapy Type
           10.2.3    By Indication
           10.2.4    By Cell Type
           10.2.5    By End-User
           10.2.6    Countries & Segments - Market Attractiveness Analysis
10.3    Asia Pacific
           10.3.1    By Country
                      10.3.1.1    China
                      10.3.1.2    Japan
                      10.3.1.3    South Korea
                      10.3.1.4    India      
                      10.3.1.5    Australia & New Zealand
                      10.3.1.6    Rest of Asia-Pacific
           10.3.2    By Therapy Type
           10.3.3    By Indication
           10.3.4    By Cell Type
           10.3.5    By End-User
           10.3.6    Countries & Segments - Market Attractiveness Analysis
10.4    South America
           10.4.1    By Country
                      10.4.1.1    Brazil
                      10.4.1.2    Argentina
                      10.4.1.3    Colombia
                      10.4.1.4    Chile
                      10.4.1.5    Rest of South America
           10.4.2    By Therapy Type
           10.4.3    By Indication
           10.4.4    By Cell Type
           10.4.5    By End-User
           10.4.6    Countries & Segments - Market Attractiveness Analysis
10.5    Middle East & Africa
           10.5.1    By Country
                      10.5.1.1    United Arab Emirates (UAE)
                      10.5.1.2    Saudi Arabia
                      10.5.1.3    Qatar
                      10.5.1.4    Israel
                      10.5.1.5    South Africa
                      10.5.1.6    Nigeria
                      10.5.1.7    Kenya
                      10.5.1.8    Egypt
                      10.5.1.9    Rest of MEA
           10.5.2    By Therapy Type
           10.5.3    By Indication
           10.5.4    By Cell Type
           10.5.5    By End-User
           10.5.6    Countries & Segments - Market Attractiveness Analysis 
Chapter 11. Stem Cell Therapy Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1    Medipost Company Limited
11.2    Anterogen Company Limited
11.3    Pharmacell Company Limited
11.4    Corestem 
11.5    NuVasive  
11.6    RTI Surgical 
11.7    AlloSource  
11.8    JCR Pharmaceuticals
11.9    Takeda Pharmaceutical Company Limited 
11.10    Holostem Terapie Avanzate Srl